Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal

European Journal of Pharmacology

Volumn 458, Issue 1-2, 2003, Pages 129-134

  D'Aquila, Paolo S ^a   Peana, Alessandra T ^a   Panin, Francesca ^a   Grixoni, Chiara ^a   Cossu, Maria ^a   Serra, Gino ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Antidepressant; Bipolar disorder; Imipramine; Mania; Rapid cycling; Supersensitivity

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; IMIPRAMINE; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG WITHDRAWAL; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REBOUND;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; IMIPRAMINE; MALE; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037223439     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02731-0     Document Type: Article

References (33)

1. Angrist B., Thompson H., Shopsin B., Gershon S. Clinical studies with dopamine-receptor stimulants. Psychopharmacologia. 44:1975;273-280.
2. Anonymous Withdrawing patients from antidepressants. Drug Ther. Bull. 37:1999;49-52.
3. Baldessarini R.J. Drugs and the treatment of psychiatric disorders - depression and mania. Hardman J.G., Limbird L.E. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. 1996;431-459 McGraw-Hill, New York.
4. Bouras N., Bridges P.K. Bromocriptine in depression. Curr. Med. Res. Opin. 8:1982;150-153.
5. 2 mesolimbic dopamine receptors in chronic fluoxetine-treated rats. Eur. J. Pharmacol. 322:1997;123-127.
6. Colonna L., Petit M., Lepine J.P. Bromocriptine in affective disorders. A pilot study. J. Affect. Disord. 1:1979;173-177.
7. Corrigan M.H., Denahan A.Q., Wright C.E., Ragual R.J., Evans D.L. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress. Anxiety. 11:2000;58-65.
8. 2 agonists induced by chronic treatment with imipramine. Pharmacol. Res. 25:1992;95-101.
9. D'Aquila P.S., Collu M., Gessa G.L., Serra G. Dizolcipine prevents the enhanced locomotor response to quinpirole induced by repeated electroconvulsive shock. Eur. J. Pharmacol. 330:1997;11-14.
10. 2 dopamine receptor sensitization induced by repeated electroconvulsive shock. J. Psychopharmacol. 11:1997;41-44.
11. D'Aquila P.S., Monleon S., Borsini F., Brain P., Willner P. Anti-anhedonic actions of the novel serotoninergic agent flibanserin, a potential rapidly acting antidepressant. Eur. J. Pharmacol. 340:1997;121-132.
12. 2-like receptor agonist quinpirole. Eur. J. Pharmacol. 395:2000;157-160.
13. D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur. J. Pharmacol. 405:2000;365-373.
14. 2-like receptor agonist quinpirole. Eur. J. Pharmacol. 416:2001;107-111.
15. Jimerson D.C. Role of dopamine mechanism in affective disorders. Meltzer H.Y. Psychopharmacology: The Third Generation of Progress. 1987;505-511 Raven Press, New York.
16. Joyce P.R. Carbamazepine in rapid cycling bipolar affective disorder. Int. Clin. Psychopharmacol. 3:1988;123-129.
17. Koukopoulos A., Reginaldi D., Minnai G., Serra G., Pani L., Johonson F.N. The long term prophylaxis of affective disorders. Gessa G.L., Fratta W., Pani L., Serra G. Depression and Mania: from Neurobiology to Treatment. Adv. Biochem. Psychopharmacol. vol. 49:1995;127-147 Raven Press, New York.
18. 2 agonists. J. Neural Transm. 76:1989;29-38.
19. Mirin S.M., Schatzberg A.F., Creasey D.E. Hypomania and mania after withdrawal of tricyclic antidepressants. Am. J. Psychiatry. 138:1981;87-89.
20. O'Brien C.P. Drug addiction and drug abuse. Hardman J.G., Limbird L.E. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. 1996;431-459 McGraw-Hill, New York.
21. Post R.M., Uhde T.W., Ballenger J.C., Squillance K.M. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am. J. Psychiatry. 48:1983;62-68.
22. Post R.M., Uhde T.W., Ballenger J.C. The efficacy of carbamazepine in affective illness. Adv. Biochem. Psychopharmacol. 39:1984;421-437.
23. Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. Correlates of antimanic response to carbamazepine. Psychiatry Res. 21:1987;71-83.
24. Prien R.F., Kupfer D.J. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am. J. Psychiatry. 143:1986;18-23.
25. Randrup A., Munkvad I., Fog R., Geriach J., Molander R., Kjeiiberg B., Scheel-Krüger J. Mania, depression and brain dopamine. Essman W.B., Valzelli S. Current Developments in Psychopharmacology. vol. 2:1975;206-248 Spectrum Publications, New York, USA.
26. Serra G., Argiolas A., Klimek V., Fadda F., Gessa G.L. Chronic treatment with antidepressant prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci. 25:1979;415-424.
27. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res. 527:1990;234-243.
28. Serra G., Collu M., D'Aquila P.S., Gessa G.L. Role of the mesolimbic system in the mechanism of action of antidepressants. Pharmacol. Toxicol. 71(Suppl. 1):1992;72-85.
29. Soares J.C. Recent advances in the treatment of bipolar mania, depression. Mixed states, and rapid cycling. Int. Clin. Psychopharmacol. 15:2000;183-196.
30. Spyraki C., Fibiger H.C. Behavioural evidence of supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desimipramine. Eur. J. Pharmacol. 74:1981;195-206.
31. Willner P. Dopamine and depression: a review of recent evidence: I. Empirical studies. Brain Res. 287:1983;211-224.
32. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia: a realistic animals model of depression. Neurosci. Biobehav. Rev. 16:1992;525-534.
33. Winer B.J. Statistical Principles in Experimental Design. 1971;McGraw Hill, London.